Investigational Drug Information for Hemay005
✉ Email this page to a colleague
What is the drug development status for Hemay005?
Hemay005 is an investigational drug.
There have been 11 clinical trials for Hemay005.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 13th 2021.
The most common disease conditions in clinical trials are Psoriasis, Colitis, Ulcerative, and Colitis. The leading clinical trial sponsors are Tianjin Hemay Pharmaceutical Co.,Ltd, Ganzhou Hemay Pharmaceutical Co., Ltd, and Tianjin Hemay Bio-Tech Co., Ltd.
There is one US patent protecting this investigational drug and seven international patents.
Summary for Hemay005
| US Patents | 1 |
| International Patents | 7 |
| US Patent Applications | 10 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 2 (2021-05-13) |
| Vendors | 5 |
Recent Clinical Trials for Hemay005
| Title | Sponsor | Phase |
|---|---|---|
| A Study of Hemay005 in Adult With Atopic Dermatitis | Ganzhou Hemay Pharmaceutical Co., Ltd | Phase 2 |
| Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis | Ganzhou Hemay Pharmaceutical Co., Ltd | Phase 2 |
| In Vivo Mass Balance Study of [14C]Hemay005 | Ganzhou Hemay Pharmaceutical Co., Ltd | Phase 1 |
Clinical Trial Summary for Hemay005
Top disease conditions for Hemay005
Top clinical trial sponsors for Hemay005
US Patents for Hemay005
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Hemay005 | ⤷ Try a Trial | Bicyclic compounds and methods of use | BioTheryX, Inc. (Chappaqua, NY) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Hemay005
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Hemay005 | Australia | AU2018285775 | 2037-06-13 | ⤷ Try a Trial |
| Hemay005 | Canada | CA3065148 | 2037-06-13 | ⤷ Try a Trial |
| Hemay005 | China | CN110997679 | 2037-06-13 | ⤷ Try a Trial |
| Hemay005 | European Patent Office | EP3638679 | 2037-06-13 | ⤷ Try a Trial |
| Hemay005 | Japan | JP2020523295 | 2037-06-13 | ⤷ Try a Trial |
| Hemay005 | Taiwan | TW201902903 | 2037-06-13 | ⤷ Try a Trial |
| Hemay005 | World Intellectual Property Organization (WIPO) | WO2018231604 | 2037-06-13 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
